Michael F. Picco, MD, PhD; Steven Goodman, MD, PhD; James Reed, PhD; Theodore M. Bayless, MD
Acknowledgment: The authors thank Gloria M. Petersen, PhD, for critical review of the manuscript.
Grant Support: By the National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health (Dr. Picco); Harvey M. and Lyn Pancoe Meyerhoff Center for Inflammatory Bowel Diseases; Glaxo Institute for Digestive Health (Dr. Picco); and the Allan Guerreri Family Fund (Dr. Picco). Dr. Bayless receives support from the Meyerhoff Center for Inflammatory Bowel Diseases, the Peter and Cynthia Rosenwald Fund, and the Steven A. Mullaney Fund.
Requests for Single Reprints: Michael F. Picco, MD, PhD, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224.
Current Author Addresses: Dr. Picco: Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224.
Dr. Goodman: Johns Hopkins University Department of Medicine, 550 Building, 600 North Wolfe Street, Baltimore, MD 21287.
Dr. Reed: Research Institute, St. Luke's Hospital, 801 Ostrum Street, Bethlehem, PA 18105.
Dr. Bayless: Johns Hopkins University Department of Medicine, Blalock 461, 600 North Wolfe Street, Baltimore, MD 21287.
Picco MF, Goodman S, Reed J, Bayless TM. Methodologic Pitfalls in the Determination of Genetic Anticipation: The Case of Crohn Disease. Ann Intern Med. 2001;134:1124-1129. doi: 10.7326/0003-4819-134-12-200106190-00013
Download citation file:
Published: Ann Intern Med. 2001;134(12):1124-1129.
The term genetic anticipation is used when genetically transmitted disease manifests at increasingly younger ages with each succeeding generation: that is, if the offspring of patients develop the disease, they will tend to do so at an earlier age than their parents. In some monogenetic disorders, genetic anticipation has a biological basis in expanded genetic triplet repeats; however, some have claimed that it occurs in polygenic disorders, such as Crohn disease, in which its mechanism cannot be explained.
To show how apparent changes in age at diagnosis of Crohn disease between generations, which could suggest genetic anticipation, can be an artifact of inadequate analysis based on age at diagnosis in cohorts that have not been followed for a sufficiently long time.
Comparison of ages at diagnosis of Crohn disease among different birth cohorts, before and after adjustment for observation time.
Meyerhoff Center for Inflammatory Bowel Disease, Johns Hopkins Hospital, Baltimore, Maryland.
928 consecutive outpatients with Crohn disease.
Trends in age at diagnosis of Crohn disease among birth cohorts were determined by calculating Pearson correlation coefficients and performing Kaplanâ€“Meyer analysis before and after adjustment for observation time. Adjustment for observation time was performed by ensuring that the time during which all included patients were at risk for Crohn disease was equal and that all patients had developed disease by the end of the risk period.
Mean age at diagnosis decreased by approximately 5 years with each subsequent 10-year birth cohort on the basis of crude cross-sectional data that could suggest genetic anticipation between generations. However, after adjustment for observation time, the age at diagnosis decreased minimally, if at all, with each successive generation.
Apparent genetic anticipation can be explained by observational biases without invoking any additional genetic influences. Claims for genetic anticipation must be based on methods that properly account for the duration of observation in all persons being studied.
Learn more about subscription options.
Register Now for a free account.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only